SEC Form 4 · accession 0001209191-17-016501
Epizyme, Inc. · EPZM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Tai-Ching Ho
Officer — Chief Development Officer
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001571498
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.0001F1,F2 | Feb 28, 2017 | A | 1,708 | $6.2135 | A | 7,228 | D | |
| Common stock, par value $0.0001F3 | holding | — | — | — | 1,000 | I | By Trust | |
| Common Stock, par value $0.0001F3 | holding | — | — | — | 1,000 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired under the Epizyme, Inc. 2013 Employee Stock Purchase Plan in connection with offering period ended February 28, 2017.
- F2These shares are held in a brokerage account jointly owned by the reporting person and his spouse.
- F3These shares are held in trust for the benefit of the reporting person's child. The reporting person's spouse is a trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.